Christopher Davis’s Community Healthcare Trust CHCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.9M Sell
322,890
-7,150
-2% -$124K 0.03% 94
2026
Q1
$5.24M Buy
330,040
+4,480
+1% +$75.6K 0.02% 98
2025
Q4
$5.35M Sell
325,560
-7,630
-2% -$114K 0.02% 94
2025
Q3
$5.1M Buy
333,190
+910
+0.3% +$14.2K 0.03% 98
2025
Q2
$5.53M Buy
332,280
+30,540
+10% +$504K 0.03% 94
2025
Q1
$5.48M Buy
301,740
+86,110
+40% +$1.64M 0.03% 90
2024
Q4
$4.14M Hold
215,630
0.02% 92
2024
Q3
$3.91M Sell
215,630
-4,360
-2% -$89.1K 0.02% 93
2024
Q2
$0 Sell
219,990
-160
-0.1% -$3.89K ﹤0.01% 77
2024
Q1
$5.84M Sell
220,150
-2,950
-1% -$77.8K 0.03% 85
2023
Q4
$5.94M Buy
223,100
+59,700
+37% +$1.64M 0.03% 88
2023
Q3
$4.85M Buy
163,400
+58,570
+56% +$1.97M 0.03% 89
2023
Q2
$3.46M Buy
104,830
+54,160
+107% +$1.88M 0.02% 94
2023
Q1
$1.85M Buy
+50,670
New +$1.98M 0.01% 97

Other funds holding CHCT

Christopher Davis's CHCT Position: Q2 2026 in Review

Christopher Davis reduced its Community Healthcare Trust (CHCT) stake by 2.2% in Q2 2026, selling an estimated $124K and leaving 322,890 shares worth $5.9M. The position accounts for 0.03% of the portfolio, ranked #94.

Christopher Davis first reported a position in CHCT in Q1 2023 and has held it in 14 quarters since. The position peaked at $5.94M in Q4 2023. 169 funds tracked by Wall St. Rank hold CHCT as of Q2 2026.

  • Christopher Davis held 322,890 shares of Community Healthcare Trust worth $5.9M as of Q2 2026.
  • Christopher Davis sold 7,150 Community Healthcare Trust shares in Q2 2026, an estimated $124K.
  • Community Healthcare Trust made up 0.03% of Christopher Davis's portfolio in Q2 2026, its #94 holding.
  • Christopher Davis first reported a position in Community Healthcare Trust in Q1 2023 and has held it in 14 quarters since.
  • Christopher Davis's Community Healthcare Trust position peaked at $5.94M in Q4 2023.
  • 169 funds tracked by Wall St. Rank held Community Healthcare Trust as of Q2 2026.

Based on Davis Selected Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.